These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 29860288)
1. Models of Trachoma Transmission and Their Policy Implications: From Control to Elimination. Lietman TM; Pinsent A; Liu F; Deiner M; Hollingsworth TD; Porco TC Clin Infect Dis; 2018 Jun; 66(suppl_4):S275-S280. PubMed ID: 29860288 [TBL] [Abstract][Full Text] [Related]
2. Ocular Chlamydia trachomatis infection: elimination with mass drug administration. Wolle MA; West SK Expert Rev Anti Infect Ther; 2019 Mar; 17(3):189-200. PubMed ID: 30698042 [TBL] [Abstract][Full Text] [Related]
3. One round of azithromycin MDA adequate to interrupt transmission in districts with prevalence of trachomatous inflammation-follicular of 5.0-9.9%: Evidence from Malawi. Kalua K; Chisambi A; Chinyanya D; Masika M; Bakhtiari A; Willis R; Emerson PM; Solomon AW; Bailey RL PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006543. PubMed ID: 29897902 [TBL] [Abstract][Full Text] [Related]
4. Coverage, social mobilization and challenges of mass Zithromax administration campaign in South and South East zones of Tigray, Northern Ethiopia: A cross sectional study. Mulugeta A; Gebregergs GB; Asfaw S; Yemane D; Mitiku M; Meresa B; Gigar G; Kidane A PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006288. PubMed ID: 29481558 [TBL] [Abstract][Full Text] [Related]
5. Mass drug administration for trachoma: how long is not long enough? Jimenez V; Gelderblom HC; Mann Flueckiger R; Emerson PM; Haddad D PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003610. PubMed ID: 25799168 [TBL] [Abstract][Full Text] [Related]
6. A rationale for continuing mass antibiotic distributions for trachoma. Ray KJ; Porco TC; Hong KC; Lee DC; Alemayehu W; Melese M; Lakew T; Yi E; House J; Chidambaram JD; Whitcher JP; Gaynor BD; Lietman TM BMC Infect Dis; 2007 Aug; 7():91. PubMed ID: 17683646 [TBL] [Abstract][Full Text] [Related]
7. Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution. Godwin W; Prada JM; Emerson P; Hooper PJ; Bakhtiari A; Deiner M; Porco TC; Mahmud H; Landskroner E; Hollingsworth TD; Medley GF; Pinsent A; Bailey R; Lietman TM; Oldenburg CE J Infect Dis; 2020 Jun; 221(Suppl 5):S519-S524. PubMed ID: 32052842 [TBL] [Abstract][Full Text] [Related]
9. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Lietman T; Porco T; Dawson C; Blower S Nat Med; 1999 May; 5(5):572-6. PubMed ID: 10229236 [TBL] [Abstract][Full Text] [Related]
10. Coverage assessment survey following trachoma mass drug administration (MDA) in six districts of Oromia, Western Ethiopia, 2017. Bekuma TT; Mosisa Kebebew G; Desalegn Waktole Z; Markos Cafo J; Wirtu D; Gaddisa S PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007924. PubMed ID: 31841516 [TBL] [Abstract][Full Text] [Related]
11. Mathematical Modelling of Trachoma Transmission, Control and Elimination. Pinsent A; Blake IM; Basáñez MG; Gambhir M Adv Parasitol; 2016; 94():1-48. PubMed ID: 27756453 [TBL] [Abstract][Full Text] [Related]
12. Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial. House JI; Ayele B; Porco TC; Zhou Z; Hong KC; Gebre T; Ray KJ; Keenan JD; Stoller NE; Whitcher JP; Gaynor BD; Emerson PM; Lietman TM Lancet; 2009 Mar; 373(9669):1111-8. PubMed ID: 19329003 [TBL] [Abstract][Full Text] [Related]
13. Eliminating trachoma in areas with limited disease. Gaynor BD; Miao Y; Cevallos V; Jha H; Chaudary JS; Bhatta R; Osaki-Holm S; Yi E; Schachter J; Whitcher JP; Lietman T Emerg Infect Dis; 2003 May; 9(5):596-8. PubMed ID: 12737745 [TBL] [Abstract][Full Text] [Related]
14. Enhanced antibiotic distribution strategies and the potential impact of facial cleanliness and environmental improvements for the sustained control of trachoma: a modelling study. Pinsent A; Burton MJ; Gambhir M BMC Med; 2016 May; 14(1):71. PubMed ID: 27194136 [TBL] [Abstract][Full Text] [Related]
15. Progress and projections in the program to eliminate trachoma. Emerson PM; Hooper PJ; Sarah V PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005402. PubMed ID: 28426814 [No Abstract] [Full Text] [Related]
16. Can we eradicate trachoma? A survey of stakeholders. Oldenburg CE; Aragie S; Amza A; Solomon AW; Brogdon J; Arnold BF; Keenan JD; Lietman TM Br J Ophthalmol; 2021 Aug; 105(8):1059-1062. PubMed ID: 32855161 [TBL] [Abstract][Full Text] [Related]
17. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa. Last AR; Burr SE; Harding-Esch E; Cassama E; Nabicassa M; Roberts CH; Mabey DCW; Holland MJ; Bailey RL Parasit Vectors; 2017 Dec; 10(1):624. PubMed ID: 29282126 [TBL] [Abstract][Full Text] [Related]
18. Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia. Stare D; Harding-Esch E; Munoz B; Bailey R; Mabey D; Holland M; Gaydos C; West S Ophthalmic Epidemiol; 2011 Feb; 18(1):20-9. PubMed ID: 21275593 [TBL] [Abstract][Full Text] [Related]
20. The cost of antibiotic mass drug administration for trachoma control in a remote area of South Sudan. Kolaczinski JH; Robinson E; Finn TP PLoS Negl Trop Dis; 2011 Oct; 5(10):e1362. PubMed ID: 22022632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]